• Join
  • Login
  • Contact

Search abstracts

In vitro release study of timolol from novel hpmc/ha composite film for glaucoma treatment

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: TIGHSAZZADEH, Mo (University of Greenwich, Chemical, Pharmaceutical & Environmental Sciences)
  • Co-author(s): Mo Tighsazzadeh
    Joshua Boateng
  • Abstract:


    For ocular drug delivery, topical eye drops are the most commonly used dosage form; however, only 5% of the applied dose is absorbed into the eye. Therefore, a more effective drug delivery system is required for severe chronic eye conditions such as glaucoma to provide appropriate bioavailability.


    Optimised 1.5% (w/v) HPMC and 1%


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 21 September 2019

FIP Congresses